 |
 |

Axillofemoral BypassExpectations and Results
Ronald A. Savrin, MD;
George T. Record, MD;
Donald E. McDowell, MD
Arch Surg. 1986;121(9):1016-1020.
Abstract
We studied 33 patients who received axillofemorofemoral or axillofemoral polytef (polytetrafluoroethylene [PTFE]) grafts. The follow-up period ranged from six to 60 months. Most patients were operated on for limb salvage. The 30-day operative mortality was 7% for elective or urgent procedures and 67% for emergency procedures. Twelve amputations were performed, but nine were necessitated by preexisting tissue loss and three were performed below rather than above the knee following proximal revascularization. Cumulative graft patency was 91% at three years and 75% at five years. Patient survival was only 54% at three years and 41% at five years. Graft patency exceeded patient survival at every interval. In a select group of high-risk patients requiring proximal revascularization for limb salvage, axillofemorofemoral bypass offers an acceptable alternative to an in situ aortofemoral graft.
(Arch Surg 1986;121:1016-1020)
Author Affiliations
From the Section of Vascular Surgery, West Virginia University, Morgantown.
Footnotes
Accepted for publication July 22, 1985.
Reprint requests to Section of Vascular Surgery, West Virginia University Medical Center, Morgantown, WV 26506-6302 (Dr Savrin).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Twenty-Year Experience with Axillofemoral Bypass: Analysis of 63 Consecutive Cases
Mingoli et al.
VASC ENDOVASCULAR SURG 1991;25:677-688.
ABSTRACT
|